Chewy CFO, GC Trim Stakes; CEO Gets 1M+ Share Grants

NEW YORK, May 1 —

Chewy filed a Regulation FD 8-K on April 28 — its third substantive filing in roughly five weeks. The more telling disclosure is buried in the Form 4s. Over the last 90 days, insiders bought zero shares on the open market and sold about $300,000 worth. Meanwhile, the board handed the CEO and CFO grants worth roughly a million shares between them.

The Open-Market Tell

The dollar amounts are small. That's the point. When insiders dump $300 million, the market notices and the stock reprices. When two officers sell $300,000 between them and nobody buys anything, that's a quieter signal — and quieter signals often carry more information, because nobody is staging them for an audience.

General Counsel Da-wai Hu sold 8,149 shares on April 1 at $26.91, raising $219,290. CFO Christopher Deppe sold 3,043 shares on March 2 at $26.87 for $81,765. Two officers, two open-market sales, no offsetting purchases anywhere in the executive ranks. Both trades cleared at prices above where the stock trades today. Whoever bought those tickets is currently underwater.

The Grant Avalanche

The compensation side ran the other way. On April 8, the board approved a stack of equity awards: 560,286 shares to CEO Sumit Singh across four grants (394,868 + 92,381 + 13,818 + 59,219), and 423,654 shares to CFO Deppe across three (71,062 + 5,922 + 346,670). General Counsel Hu received 37,486 shares the same day. Chief Accounting Officer William Billings got 32,571.

That came on top of an earlier wave on March 25, the same day Chewy filed its Item 2.02 earnings 8-K. Singh collected another 526,284 plus 47,653 shares. Hu got 49,962, Billings 14,470, Deppe 4,342. The CEO alone received more than 1.1 million shares in grants across the two dates.

Stacking grants on the day of an earnings release is legal and common. It's also worth flagging. Boards know the share price on grant date. CEOs know the earnings print before the board does. When the two events line up by design, the strike price on restricted stock gets fixed against a known, controlled information set. Chewy isn't unique in doing this. But the size of Singh's package — over a million shares at recent prices, north of $25 million in stock — concentrates the issue.

The Tax-Withholding Footnote

One more data point sits in the Form 4 trail. On February 27, Singh disposed of 30,267 shares at $26.97 ($816,301) and another 5,090 at the same price ($137,277) via tax-withholding. Those aren't open-market sales. They're shares surrendered back to the company to cover the tax bill on vesting equity — a mechanical event, no discretionary signal. A smaller 1,021-share withholding tick followed on April 1 at $27.00.

These matter because they confirm the equity machine is running at scale. Big grants vest, big tax withholdings follow, and on top of that, executives still chose to trim modestly on the open market. The discretionary trades, not the mechanical ones, are the part to watch.

Why the Setup Is Mixed, Not Bearish

Chewy is not a melting ice cube. Trailing twelve-month revenue is $12.60 billion, gross margin 29.8%, free cash flow $453 million. The business converts. Earnings have beaten consensus three quarters running — $0.35 vs. $0.34, $0.33 vs. $0.33, and $0.32 vs. $0.30. Modest beats, the kind that suggest guidance is being managed conservatively. At a forward P/E of 12.9x, this is not priced like a story stock.

The bull case has a number attached: a $40.81 mean analyst target, roughly 61% above the $25.31 share price. Vanguard Capital Management reportedly disclosed a 12.19 million-share stake per Stock Titan — a sign at least some long-only money sees the gap as opportunity, not warning.

The cautious read: revenue growth is 0.5%. A pet retailer printing flat top-line numbers can't earn its way to a re-rating on cost discipline alone. And insiders, who see next quarter's run-rate before anyone else, were happy to take chips off the table at prices above today's quote.

What to Watch

The April 28 Reg FD filing didn't move the tape. But it sits in the same five-week window as $300,000 of insider selling and 1.6 million shares in fresh executive grants. Watch the next earnings 8-K for whether the 0.5% growth rate has inflected. Watch the Form 4 stream for any open-market buying — at $25, executives have a clean opportunity to put their money where the analyst targets are. So far, none has.

Neutral here. The valuation isn't expensive, the cash flow is real, the analyst gap is wide. But the insider posture, mild as it is, is the wrong shape for a confident long. A few open-market purchase tickets would change the picture quickly.

Run the free Chewy, Inc. deep-dive →

strong>

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

Are Chewy insiders selling stock?

Yes. Over the last 90 days, Chewy insiders logged roughly $300,000 in open-market sales and zero open-market purchases, with the CFO and General Counsel both trimming positions as detailed in the filing analysis above.

How many shares did Chewy's CEO get in 2026?

CEO Sumit Singh received grants totaling 560,286 shares on April 8 and 573,937 shares on March 25, alongside tax-withholding dispositions on vested stock as detailed above.

Is CHWY stock undervalued at $25.31?

The 12.9x forward P/E and $453M free cash flow base look reasonable, but revenue growth of 0.5% leaves a 61% gap to the $40.81 mean analyst target unresolved, as the report explains.

What did Chewy disclose in its April 28 8-K?

Chewy filed an 8-K on April 28, 2026 under Item 7.01 (Regulation FD Disclosure). The filing is linked in the analysis above.

Did Chewy beat earnings estimates?

Yes — Chewy beat consensus EPS in each of the last three reported quarters ($0.35, $0.33, and $0.32 versus estimates of $0.339, $0.332, and $0.304), as detailed in the fundamentals section above.